Gerd Noeldge MD, PhD, Presenter: Nothing to Disclose

Katharina Da Fonseca, Abstract Co-Author: Nothing to Disclose

Christian Kasperk, Abstract Co-Author: Nothing to Disclose

Martin Libicher MD, Abstract Co-Author: Nothing to Disclose

Peter Juergen Meeder MD, PhD, Abstract Co-Author: Nothing to Disclose

Guenter W. Kauffmann MD, PhD, Abstract Co-Author: Nothing to Disclose

The effect of a new resorbable calciumphosphate cement (Calcibon) for restauration and stabilization of traumatic and osteoporotic fractures in younger patients was evaluated.

Between May 2002 and November 2004 kyphoplasty procedures with calciumphosphate cement were performed.

Calcibon was applied in 182 vertebral bodies in 98 patients. The treated vertebrae were located between the 9th thoracic and the 5th lumbar vertebral body. Procedural time was 55 minutes on the average, applicating between 4 to 9 ml Calcibon. Dislocation of the bone cement occured in about 19%. VAS-studies resultes in pain reductions of 90.5% postoperatively. Radiomorphometric analysis revealed an augmentation of the original vertebral high from 62% to 69%. CT-evaluations in the follow-up studies up to 12 months could not yet visualize zones of resorption between Calcibon and the surrounding bone tissue.

The application of Calcibon in younger patients with traumatic and or osteoporotic fractures seems to be a convincing alternative to the established PMMA cement.

Noeldge, G, Da Fonseca, K, Kasperk, C, Libicher, M, Meeder, P, Kauffmann, G, Use of Calicbon: A New Therapeutic Aspect in Kyphoplasty.  Radiological Society of North America 2005 Scientific Assembly and Annual Meeting, November 27 - December 2, 2005 ,Chicago IL. http://archive.rsna.org/2005/4410000.html